TORRENT PHARM (TORNTPHARM.NS) Financials
TORNTPHARM.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 147.4 billion | 80.4 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 150.1 billion | 88.1 billion |
TORNTPHARM.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 4.3 billion | ? |
| 2023-09-30 | 4.0 billion | ? |
| 2023-06-30 | 3.8 billion | ? |
| 2023-03-31 | 3.9 billion | ? |
TORNTPHARM.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 4.4 billion |
| 2023-09-30 | 3.9 billion |
| 2023-06-30 | 3.8 billion |
| 2023-03-31 | 3.0 billion |
TORNTPHARM.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 9.4 billion | 21.6 billion | 730.0 million |
| 2023-06-30 | 7.2 billion | - | - |
| 2023-03-31 | 8.4 billion | 25.5 billion | 710.0 million |
TORNTPHARM.NS Shares Outstanding
TORNTPHARM.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 1.3 billion | - | - |
| 2023-09-30 | 1.8 billion | 1.3 billion | 5.0 billion | - |
| 2023-06-30 | - | 1.3 billion | 5.0 billion | - |
| 2023-03-31 | 5.7 billion | 1.5 billion | 4.4 billion | - |
TORNTPHARM.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 26.9 billion | 7.0 billion |
| 2023-09-30 | 26.3 billion | 6.6 billion |
| 2023-06-30 | 25.5 billion | 6.5 billion |
| 2023-03-31 | 24.5 billion | 7.0 billion |
TORNTPHARM.NS
Price: ₹2,698.70
Dividend Yield: 0.01%
Forward Dividend Yield: 1.63%
Payout Ratio: 99.44%
Dividend Per Share: 44.00 INR
Earnings Per Share: 44.27 INR
P/E Ratio: 60.01
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 875.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%